Vaxart Announces First Subject Enrolled in Phase 1b Norovirus Boosting Regimen Study
Study will evaluate safety and immunogenicity of multiple distinct dosing regimens of norovirus oral vaccine candidate Norovirus infects 15% of...
Study will evaluate safety and immunogenicity of multiple distinct dosing regimens of norovirus oral vaccine candidate Norovirus infects 15% of...
Webinar on Thursday, May 13th @ 1pm ETCARLSBAD, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI),...
ESKAPE Pathogens: Standardised and Drug Resistant Broad Efficacious Dosing Range Figure 1 Minimum inhibitory concentration (ppm) of RECCE® 327 against...
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...
Results allow the Company to advance development, including planning for its multiple-ascending dose clinical studyREDWOOD CITY, Calif., May 04, 2021...
EAGLE, Idaho, May 04, 2021 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries...
NEW YORK, May 04, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and...
Data showed reduction of neovascular lesion formation and vascular leakage in a rodent model of choroidal neovascularizationABP201 performed equally or...
BOSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ: YMTX), a biopharmaceutical company focused on the development of innovative,...
Ann Cunningham has a proven pharmaceutical commercial track record of more than 25 years delivering sales, marketing, and global life...
Hosted conference call to begin at 4:30 p.m. ETNEW YORK, May 04, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”)...
LONDON and REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or “the...
-Data from studies of novel AAV vectors and AAV immunology and an encore of 12-month safety, efficacy and patient-reported outcomes...
New leading international life science investors join current institutional investors with proceeds to: Advance novel, late-stage Investigational ophthalmology drugs OCS-01...
Results Show Improvement in Multiple Behavioral Domains Following Treatment with DCCR Data Presented in a Poster at the Pediatric Academic...
ROCKAWAY, NJ, May 04, 2021 (GLOBE NEWSWIRE) -- -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the...
- Leverages large genomic database from Scipher’s testing business.- Proven Spectra™ platform brings precision therapeutics to autoimmune diseases.- Program commercialized through...
MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular...
- Highest dose cohorts confirm and extend previously-reported 3 mg/kg IV cohort data -- 10 mg/kg IV dose provides full...
MONTREAL, May 04, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research,...